Living Donor Liver Transplantation for Hepatocellular Carcinoma: Appraisal of the United Network for Organ Sharing Modified TNM Staging
Background: In deceased donor liver transplantation (DDLT), transplant eligibility for T3–T4 HCC requires successful downstaging (DS). Living donor liver transplantation (LDLT) can be considered selectively in these patients without DS, but its role is not defined. The objective of the current study...
Main Authors: | Abu Bakar Hafeez Bhatti, Anum Waheed, Nasir Ayub Khan |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-01-01
|
Series: | Frontiers in Surgery |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fsurg.2020.622170/full |
Similar Items
-
Letter regarding “Feasibility of additional radiotherapy in patients with advanced hepatocellular carcinoma treated with atezolizumab plus bevacizumab”
by: Sun Hyun Bae, et al.
Published: (2023-09-01) -
Roles and regulation of histone acetylation in hepatocellular carcinoma
by: Jin-kun Xia, et al.
Published: (2022-08-01) -
Landscape of Immune Cells Heterogeneity in Liver Transplantation by Single-Cell RNA Sequencing Analysis
by: Xinqiang Li, et al.
Published: (2022-05-01) -
Radiation therapy in the era of immune treatment for hepatocellular carcinoma
by: Lingjuan Chen, et al.
Published: (2023-01-01) -
TNM Staging System in Thymoma: A Critical Appraisal?
by: Marcello Carlo Ambrogi, et al.
Published: (2024-01-01)